Four Stanford students brought home $5000 from the second annual Policy Hackathon, a data-driven policy innovation competition sponsored by the Stanford Institute for Economic Policy Research (SIEPR) and Stanford in Government (SIG).
Today, a new generation of innovative biomedical startups continue to win billion-dollar valuations and massive infusions of venture capital as they promise to revolutionize medicine and disrupt massive healthcare markets. According to a new January paper authored by three Stanford researchers, many of these companies also publish little to no peer-reviewed research.
Stanford has launched a review into several faculty members’ ties to He Jiankui, a former postdoctoral fellow who claimed in November that he had successfully edited the embryos of twin girls.
Stanford paused its research partnership with the Chinese telecom conglomerate Huawei in mid-December in light of the U.S. government’s warning against potential cybersecurity risks associated with the company.
On Thursday, a team led by assistant professor of bioengineering Stanley Qi released a study on a new form of gene-editing technology known as Clustered Regularly Interspaced Short Palindromic Repeats genome organization, or CRISPR-GO, which allows scientists to move pieces of DNA within a cell nucleus. In contrast, previous CRISPR technology has been used to “cut” and “paste” sections of the genetic code within individual pieces of DNA.
While the book focuses on ten traits, Hennessy’s remarks centered around only four: humility, empathy, collaboration and storytelling. Hennessy shared several anecdotes from his tenure as University president.
Stanford postdoctoral student Yiyin Erin Chen was one of fifteen nationally selected recipients of an up to $1.4 million Hanna Gray Fellowship award from the Howard Hughes Medical Institute (HHMI).
As the 2019 Gordon Research Conference — “Wnt Signaling Networks in Development, Disease and Regeneration” — approaches, Stanford developmental biology professor Roeland Nusse is continuing more than 30 years of work with the protein known as Wnt. He leads the Nusse Lab at Stanford in researching the effects and mechanisms of Wnt signaling, which has profound consequences on stem cell fate, tissue regeneration and cancer.